Inquire Now

Orthopedics

Excel Life Sciences (ELS) has significant experience in running and supporting clinical trials for orthopedic disorders and diseases in India. In fact, ELS has one of the largest networks of investigative sites and investigators in India, including some of the countries leading investigators and centers treating orthopedic conditions. In India, the science of orthopedics is quickly evolving. Today there are approximately 20,000 practitioners throughout the country and this number continues to increase. One of the most prevalent conditions in this therapeutic area is Arthritis where there are more than 150 million patients currently under treatment. Many top Orthopedics centers in India are reporting an average overall increase in out patients of 5%–10% per year.

Investigative sites within the ELS network have the experience and infrastructure necessary to conduct global clinical trials requiring the highest levels of ethics, quality and performance. These institutions specialize in the latest techniques and treatments in the area of orthopedics including minimally invasive surgery, cartilage and bone transplantation, spine surgery and limb sparing surgery. They have deep access to a diverse treatment naive patient pool, with each seeing more than 100 new patients every month. Data from our sites suggests that between the years 2003 to 2006 the leading Investigators treated approximately 70,000 patients in this therapeutic area. Many patients are treatment naïve and non-transient. These factors typically result in shortened enrollment times.

Using sophisticated databases of detailed site information, demographics and epidemiology data we can quickly determine if India is the right fit for your study. In addition, ELS can quickly mobilize a team of experienced project managers to conduct a study feasibility analysis and determine the appropriate sites and availability of patients. We have significant experience in the area of orthopedics and we are confident that we can assist you with your next study. Contact our business development team today to learn more!